HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies.
Coyle D, Durand-Zaleski I, Farrington J, Garrison L, Graf von der Schulenburg JM, Greiner W, Longworth L, Meunier A, Moutié AS, Palmer S, Pemberton-Whiteley Z, Ratcliffe M, Shen J, Sproule D, Zhao K, Shah K.
Coyle D, et al. Among authors: shen j.
Eur J Health Econ. 2020 Dec;21(9):1421-1437. doi: 10.1007/s10198-020-01212-w. Epub 2020 Aug 13.
Eur J Health Econ. 2020.
PMID: 32794011